CAS: 1375469-38-7
BAY1082439
CAS:1375469-38-7
BAY1082439, an orally bioavailable, selective inhibitor of PI3Kα/β/δ, demonstrates high efficacy in inhibiting the growth …
Formula:
C25H30N6O5
Purity:
100%
Color and Shape:
Solid
Molecular weight:
494.54
Ref: TM-T14511
| 1mg | 37.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 79.00 € | ||
| 10mg | 119.00 € | ||
| 25mg | 188.00 € | ||
| 50mg | 350.00 € | ||
| 100mg | 522.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025
Ref: 54-BUP02028
| 25mg | 291.00 € | ||
| 50mg | 523.00 € | ||
| 100mg | 779.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
![(R)-N-(8-(2-Hydroxy-3-morpholinopropoxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-2-met…](https://static.cymitquimica.com/products/3D/thumb/AFC46938.jpg)
(R)-N-(8-(2-Hydroxy-3-morpholinopropoxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-2-methylnicotinamide
CAS:1375469-38-7
Please enquire for more information about (R)-N-(8-(2-Hydroxy-3-morpholinopropoxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-2-methylnicotinamide including the price, delivery time and more detailed …
Formula:
C25H30N6O5
Purity:
Min. 95%
Molecular weight:
494.5 g/mol
Ref: 3D-AFC46938
| 25mg | 1,016.00 € | ||
| 50mg | 1,414.00 € | ||
| 100mg | 2,202.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
